查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829747

2025年多重PCR檢測全球市場報告

Multiplex PCR Assays Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，多重PCR檢測市場快速擴張，市場規模從2024年的15.1億美元成長至2025年的17億美元，複合年成長率為12.8%。預測期內的成長歸因於感染疾病病率的上升、政府資金和支持的增加、臨床診斷應用的增加、基因檢測和個性化醫療的增加、學術研究實驗室應用的增加、生物資訊學和數據分析工具的進步以及醫療保健支出的增加。

預計未來幾年，多重PCR檢測市場將快速成長，到2029年將達到28億美元，複合年成長率為13.3%。預測期內的成長動力包括：應用領域不斷擴大、照護現場診斷需求不斷成長、個人化醫療發展、研發支出不斷增加、健康意識和預防性醫療保健日益增強、精準醫療日益受到重視，以及對快速可靠診斷檢測的需求不斷成長。預測期內的主要趨勢包括：次世代定序(NGS) 整合、伴隨診斷、數位PCR技術、自動化和高通量系統、照護現場和可攜式設備、客製化和多重偵測能力、人工智慧和機器學習、增強型資料管理以及雲端解決方案。

多重PCR檢測是一種先進的聚合酵素鏈鎖反應)技術，旨在透過單次反應同時擴增和檢測多個DNA或RNA標靶。此方法可同時分析多種遺傳標記和病原體，提供全面、經濟高效的檢測結果，並顯著提高效率。

多重PCR檢測主要分為平面PCR和以微珠為基礎。平面PCR檢測在平面或平台（例如微孔盤或玻片）上進行，並安裝探針陣列以檢測單一樣本中的多個靶標，從而實現高效、高通量分析。產品和服務包括應用於疾病診斷、研發等領域的耗材、儀器、軟體和服務。這些技術的最終用戶包括生物製藥公司、臨床研究實驗室、學術研究機構和診斷中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是一家商業研究公司發布的一系列新報告的一部分，該系列報告提供多重 PCR 檢測市場統計數據，例如全球市場規模、區域佔有率、競爭對手的多重 PCR 檢測市場佔有率、詳細的多重 PCR 檢測細分市場、市場趨勢和商機，以及您在多重 PCR 檢測行業取得成功所需的數據。本多重 PCR 檢測市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為13.3%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響將透過對芬蘭專用聚合酵素徵收關稅直接影響美國，這可能會增加綜合診斷試劑盒的成本，並限制多病原體檢測試劑的供應。此外，互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響也將更廣泛地反映出來。

診斷檢測需求的不斷成長預計將推動多重PCR檢測市場的擴張。診斷檢測包括用於確定患者是否有疾病或病症的程序和測試。癌症和糖尿病等慢性疾病的日益流行，需要早期準確的診斷才能有效管理。此外，對預防性醫療保健的重視也推動了定期檢測，以便及早發現潛在的健康問題。多重PCR檢測能夠從單一樣本同時檢測和分析多種病原體和遺傳標記，從而提高診斷檢測的效率和準確性。例如，英國國家醫療服務體系（NHS）在2024年7月報告稱，2023年的診斷活動超過了疫情前的水平，2024年5月進行的檢測同比成長了21%。此外，2024年5月進行了240萬次診斷測試。這種日益成長的診斷檢測需求預計將推動多重PCR檢測市場的成長。

多重PCR檢測市場的主要企業正致力於整合自動化技術，例如新一代定量PCR (qPCR) 系統，以提高核酸定量的準確性和靈活性，從而服務於先進的臨床診斷和公共衛生領域。新一代qPCR系統能夠實現高通量、高精度和多靶點同時檢測，進而提高診斷的準確性和效率。例如，2023年11月，瑞士診斷系統解決方案供應商羅氏診斷公司 (Roche Diagnostics Corporation) 宣布推出LightCycler PRO系統。此新一代qPCR平台具有高通量、高精度和多靶點同時檢測的特點，並具有更高的溫度均勻性、先進的軟體，以及與200多種LightMix Modular檢測試劑盒和60多種CE-IVD檢測試劑盒的兼容性。此次發布標誌著自動化技術在多重PCR檢測市場的引進，將推動臨床診斷和公共衛生事業的發展。

2023年7月，德國生物技術公司QIAGEN NV與Niba Labs達成合作。此次合作旨在透過提供尖端工具、數據分析和專業知識，推動基因組檢測和個人化醫療領域的研究，從而促進生物技術和醫療保健領域的創新。 Niba Labs是一家總部位於美國的生物技術公司，專注於基因組研究、分子診斷和個人化醫療產品的開發和生產。

多重PCR檢測市場包括逆轉錄多重PCR（RT-多重PCR）、數位多重PCR、終點多重PCR、多重連接依賴性探針擴增（MLPA）和基於探針的多重PCR的銷售。該市場的價值是指“出廠價”，即產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球多重 PCR 檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球多重PCR檢測市場：成長率分析
  • 全球多重 PCR 檢測市場表現：規模與成長，2019-2024 年
  • 全球多重 PCR 檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球多重 PCR 檢測：總潛在市場 (TAM)

第6章 市場細分

  • 全球多重 PCR 檢測市場（依檢測類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 平面測定
  • 以微珠為基礎的檢測
  • 全球多重 PCR 檢測市場（依產品及服務分類）、實際及預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 耗材
  • 裝置
  • 軟體和服務
  • 全球多重PCR檢測市場：依應用、實際及預測，2019-2024年、2024-2029年、2034年
  • 疾病診斷
  • 研究與開發
  • 其他用途
  • 全球多重 PCR 檢測市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物製藥公司
  • 臨床研究所
  • 學術研究機構
  • 診斷中心
  • 其他最終用戶
  • 全球多重 PCR 檢測市場：依平面檢測類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 基於微陣列的偵測
  • DNA晶片檢測
  • 全球多重 PCR 檢測市場：以微珠為基礎的檢測方法細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • Luminex Xmap 檢測
  • Magpix 檢測
  • 基於流式細胞技術的珠子分析

第7章 區域和國家分析

  • 全球多重 PCR 檢測市場：區域分析、預測與成長（2019-2024 年、2024-2029 年及 2034 年）
  • 全球多重 PCR 檢測市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 多重 PCR 檢測市場：競爭格局
  • 多重 PCR 檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Siemens Healthineers
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • DiaSorin SpA
  • Bio-Techne Corporation
  • Promega Corporation
  • Randox Laboratories Ltd.
  • BioFire Diagnostics Inc.
  • Seegene Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年多重PCR檢測市場：提供新機會的國家
  • 2029年多重PCR檢測市場：細分領域帶來新機會
  • 2029年多重PCR檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30750u

Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.

The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The multiplex PCR assays market research report is one of a series of new reports from the business research company that provides multiplex PCR assays market statistics, including multiplex PCR assays industry global market size, regional shares, competitors with an multiplex PCR assays market share, detailed multiplex PCR assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex PCR assays industry. This multiplex PCR assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.7 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to the increased prevalence of infectious diseases, increasing government funding and support, increasing adoption in clinical diagnostics, rise in genetic testing and personalized medicine, increasing use in academic and research institutions, advancements in bioinformatics and data analysis tools, rising healthcare expenditure.

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, an increase in research and development expenditures, rising health awareness and preventive healthcare, an increasing focus on precision medicine, and a and a rising demand for rapid and reliable diagnostic tests. Major trends in the forecast period include next-generation sequencing (NGS) integration, companion diagnostics, digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, customization and multiplexing capabilities, artificial intelligence and machine learning, enhanced data management, and cloud solutions.

The forecast of 13.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on specialized polymerase enzymes from Finland, increasing expenses for comprehensive diagnostic panels and potentially limiting the availability of multi-pathogen detection tests.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.

Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.

In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex pcr assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex PCR Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Assay Type: Planar Assay; Bead Based Assay
  • 2) By Product And Services: Consumables; Instruments; Software And Services
  • 3) By Application: Disease Diagnosis; Research And Development; Other Applications
  • 4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays
  • 2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc; PerkinElmer Inc; Illumina Inc; Sysmex Corporation; Bio-Rad Laboratories Inc; QIAGEN NV; Tecan Group Ltd; DiaSorin SpA; Bio-Techne Corporation; Promega Corporation; Randox Laboratories Ltd; BioFire Diagnostics Inc; Seegene Inc; Quanterix Corporation; NanoString Technologies; Standard BioTools Inc; Enzo Biochem Inc; SeraCare Life Sciences Inc; Agena Bioscience; Fluidigm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex PCR Assays Market Characteristics

3. Multiplex PCR Assays Market Trends And Strategies

4. Multiplex PCR Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Multiplex PCR Assays Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Multiplex PCR Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Multiplex PCR Assays Market Growth Rate Analysis
  • 5.4. Global Multiplex PCR Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Multiplex PCR Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Multiplex PCR Assays Total Addressable Market (TAM)

6. Multiplex PCR Assays Market Segmentation

  • 6.1. Global Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Planar Assay
  • Bead Based Assay
  • 6.2. Global Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • Software And Services
  • 6.3. Global Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Diagnosis
  • Research And Development
  • Other Applications
  • 6.4. Global Multiplex PCR Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Research Institutes
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Multiplex PCR Assays Market, Sub-Segmentation Of Planar Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarray-Based Assays
  • Dna Chip-Based Assays
  • 6.6. Global Multiplex PCR Assays Market, Sub-Segmentation Of Bead Based Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminex Xmap Assays
  • Magpix Assays
  • Flow Cytometry-Based Bead Assays

7. Multiplex PCR Assays Market Regional And Country Analysis

  • 7.1. Global Multiplex PCR Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Multiplex PCR Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex PCR Assays Market

  • 8.1. Asia-Pacific Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex PCR Assays Market

  • 9.1. China Multiplex PCR Assays Market Overview
  • 9.2. China Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex PCR Assays Market

  • 10.1. India Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex PCR Assays Market

  • 11.1. Japan Multiplex PCR Assays Market Overview
  • 11.2. Japan Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex PCR Assays Market

  • 12.1. Australia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex PCR Assays Market

  • 13.1. Indonesia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex PCR Assays Market

  • 14.1. South Korea Multiplex PCR Assays Market Overview
  • 14.2. South Korea Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex PCR Assays Market

  • 15.1. Western Europe Multiplex PCR Assays Market Overview
  • 15.2. Western Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex PCR Assays Market

  • 16.1. UK Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex PCR Assays Market

  • 17.1. Germany Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex PCR Assays Market

  • 18.1. France Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex PCR Assays Market

  • 19.1. Italy Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex PCR Assays Market

  • 20.1. Spain Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex PCR Assays Market

  • 21.1. Eastern Europe Multiplex PCR Assays Market Overview
  • 21.2. Eastern Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex PCR Assays Market

  • 22.1. Russia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex PCR Assays Market

  • 23.1. North America Multiplex PCR Assays Market Overview
  • 23.2. North America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex PCR Assays Market

  • 24.1. USA Multiplex PCR Assays Market Overview
  • 24.2. USA Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex PCR Assays Market

  • 25.1. Canada Multiplex PCR Assays Market Overview
  • 25.2. Canada Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex PCR Assays Market

  • 26.1. South America Multiplex PCR Assays Market Overview
  • 26.2. South America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex PCR Assays Market

  • 27.1. Brazil Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex PCR Assays Market

  • 28.1. Middle East Multiplex PCR Assays Market Overview
  • 28.2. Middle East Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex PCR Assays Market

  • 29.1. Africa Multiplex PCR Assays Market Overview
  • 29.2. Africa Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex PCR Assays Market Competitive Landscape And Company Profiles

  • 30.1. Multiplex PCR Assays Market Competitive Landscape
  • 30.2. Multiplex PCR Assays Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex PCR Assays Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Becton Dickinson and Company
  • 31.3. Agilent Technologies Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Illumina Inc.
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN NV
  • 31.9. Tecan Group Ltd.
  • 31.10. DiaSorin SpA
  • 31.11. Bio-Techne Corporation
  • 31.12. Promega Corporation
  • 31.13. Randox Laboratories Ltd.
  • 31.14. BioFire Diagnostics Inc.
  • 31.15. Seegene Inc.

32. Global Multiplex PCR Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex PCR Assays Market

34. Recent Developments In The Multiplex PCR Assays Market

35. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies

  • 35.1 Multiplex PCR Assays Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Multiplex PCR Assays Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Multiplex PCR Assays Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer